Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Jul 2025 for Cellectar Biosciences, Inc., €42k. Read the official filing
Filing timeline
BuySaleJames Caruso V
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+43.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
James Caruso V: trading record in brief
James Caruso V discloses dealings in Cellectar Biosciences, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 8 December 2023 and the latest from 2 July 2025.
The open-market record is one-sided, with 1 purchase worth €42k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. So far in 2025, the count stands at 1 purchase and no sales.
On 3 July 2025 came the latest disclosure, an open-market purchase for €42k in Cellectar Biosciences, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James Caruso V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 shares@ US$4.99Common StockSEC:0001104659-25-065573:0
Canonical exit: 30 Sept 2025 (T+90)
40,596 shares0Common StockSEC:0001104659-23-125483:0
2 of 2 declarations
